Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ENDPOINT HEALTH logo — Precision immunology therapies

ENDPOINT HEALTH

Precision immunology therapies

Founded 2018 United States Palo Alto, United States 7 employees Series A Total: $64.00M Health Care

General Information

Company Name ENDPOINT HEALTH
Founded Year 2018
Location United States Palo Alto, United States
Founders / Decision Makers
Team member Team member
Employees 7
Industries Health Care
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Value Based Pricing, Licensing
Social

BounceWatch is an independent company data service, not affiliated with ENDPOINT HEALTH. To contact ENDPOINT HEALTH, visit endpointhealth.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ENDPOINT HEALTH compare?

A PDF of ENDPOINT HEALTH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ENDPOINT HEALTH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ENDPOINT HEALTH

ENDPOINT HEALTH, founded in 2018, is gaining traction in the Health Care industry by focusing on Precision immunology therapies. Based in the United States, this company is carving out a niche with its innovative approach to treating immune-mediated chronic and acute diseases.

By leveraging a proprietary artificial intelligence (AI) platform, ENDPOINT HEALTH combines companion diagnostics with therapeutics to create precision therapies tailored to the unique biology and disease of each patient. With its vision of personalized treatment for all, the company addresses significant unmet needs and presents a valuable opportunity within a rapidly evolving sector.

The company's promising trajectory was reinforced by a substantial $52.00M Series A investment on 02 June 2022. This funding round saw participation from a notable consortium of investors including The Venture Collective (TVC), Wireframe Ventures, Boom Capital Ventures, and others. This diverse pool of backers underlines confidence in ENDPOINT HEALTH's strategic direction and potential for impactful growth.

Business keywords: Precision immunology, Therapeutics, Precision therapies, Companion diagnostics, Artificial intelligence, Chronic diseases, Acute diseases, Immune-mediated diseases, Precision medicine, AI platform, Patient-centric treatment, Drug development, Biological precision, Data-driven therapies

Services & Products

AI-Powered Website Building
Digital Optimization Tools
User Experience Enhancement

Target Customers

Startups Small to Medium Enterprises Freelancers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed -
02 Jun 2022
Series A $52.00M 10
The Venture Collective (TVC) Wireframe Ventures Boom Capital Ventures
The Venture Collective (TVC), Wireframe Ventures +8
02 Jun 2022
Series A Undisclosed 4
Knockout Capital YAYA Capital GRIDS Capital
Knockout Capital, YAYA Capital +2
09 Feb 2022
Venture Round $12.00M 5
Y Combinator AME Cloud Ventures Wireframe Ventures
Y Combinator, AME Cloud Ventures +3
13 Jul 2020
Debt Financing Undisclosed -
13 Jul 2020
Venture Round Undisclosed 1
Y Combinator
Y Combinator
22 Mar 2019

ENDPOINT HEALTH Alternatives & Competitors

View All Alternatives
ENDPOINT HEALTH vs
Alumis
Alumis United States

Transforming the lives of patients living with immune-mediated diseases using a precision approach.

Series C
249 employees
Biotechnology, Health Care
Compare ENDPOINT HEALTH vs Alumis
ENDPOINT HEALTH vs
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. United States

Revolutionizing medicine with precision.

Post-IPO Equity
31 employees
Biotechnology, Health Care
ENDPOINT HEALTH vs
Mirador Therapeutics
Mirador Therapeutics

Redefining Immunology and Inflammation with Precision

Series B
95 employees
Biotechnology, Health Care
Compare ENDPOINT HEALTH vs Mirador Therapeutics
View all alternatives

FAQ About ENDPOINT HEALTH

Precision immunology therapies
ENDPOINT HEALTH was founded in 2018.
ENDPOINT HEALTH is headquartered in Palo Alto, United States.
ENDPOINT HEALTH operates in Health Care. Its work centres on Precision immunology, Therapeutics, Precision therapies and Companion diagnostics. Its customers include Startups, Small to Medium Enterprises and Freelancers.
ENDPOINT HEALTH has a B2B and B2B2C business model. Its revenue comes from Product Sales, Value Based Pricing and Licensing.
ENDPOINT HEALTH has approximately 7 employees.
ENDPOINT HEALTH has completed 6 funding rounds, raising a total of $64.00M. The latest funding stage is Series A.
ENDPOINT HEALTH offers: AI-Powered Website Building, Digital Optimization Tools, User Experience Enhancement.
Top alternatives and competitors to ENDPOINT HEALTH include Alumis, Prometheus Biosciences, Inc., Mirador Therapeutics, HMNC Brain Health, 13therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ENDPOINT HEALTH and Alumis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ENDPOINT HEALTH, https://bouncewatch.com/company/endpoint-health, updated 21 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout